Skip to main content

Jeff Lagasse

By Jeff Lagasse | 04:19 pm | February 21, 2022
This spending growth resulted from strong federal support in 2020 and waning support in 2021, the numbers showed.
By Jeff Lagasse | 12:34 pm | February 21, 2022
The move was made to avoid potential staffing issues and to give healthcare workers more time to comply.
By Jeff Lagasse | 04:04 pm | February 18, 2022
The expectation is that customers will be able to minimize the risk of missing rebate program revenue targets and receive rebate funds more quickly.
By Jeff Lagasse | 11:05 am | February 18, 2022
Costs per single treatment for drugs administered in hospitals were an average of $7,000 more than those purchased through specialty pharmacies.
By Jeff Lagasse | 04:50 pm | February 17, 2022
With specialty drug costs projected to reach $505 billion by 2023 by the company's estimates, Optum has tapped into a potential market opportunity.
By Jeff Lagasse | 12:39 pm | February 17, 2022
Sara Serritella of the University of Chicago will spin her tale during the HIMSS22 annual conference in Orlando next month.
By Jeff Lagasse | 04:12 pm | February 16, 2022
Alcohol use has been on the rise, and nearly 60% of people have increased their drinking during the pandemic, numbers show.
By Jeff Lagasse | 11:16 am | February 16, 2022
UnitedHealthcare, for its part, is negotiating to bring Mayo in-network for MA members, citing the importance of continuity of care.
By Jeff Lagasse | 04:24 pm | February 15, 2022
The bill comes in the wake of a U.S. Supreme Court decision blocking President Biden's nationwide vaccine mandate for large employers.
By Jeff Lagasse | 12:45 pm | February 15, 2022
Kaiser Chair and CEO Greg Adams said the COVID-19 pandemic continues to impact the system, leading to income and margin pressures.